PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 116 filers reported holding PROVENTION BIO INC in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,739,442 | -9.6% | 72,176 | -60.3% | 0.10% | -10.0% |
| Q4 2022 | $1,923,529 | +92.9% | 181,980 | -17.9% | 0.11% | +89.7% |
| Q3 2022 | $997,000 | +10.4% | 221,601 | -1.9% | 0.06% | +31.8% |
| Q2 2022 | $903,000 | -43.9% | 225,785 | +2.6% | 0.04% | -31.2% |
| Q1 2022 | $1,611,000 | +39.0% | 220,065 | +6.7% | 0.06% | +56.1% |
| Q4 2021 | $1,159,000 | -25.0% | 206,215 | -14.6% | 0.04% | -28.1% |
| Q3 2021 | $1,545,000 | -22.3% | 241,411 | +2.3% | 0.06% | -19.7% |
| Q2 2021 | $1,989,000 | -23.3% | 235,924 | -4.6% | 0.07% | -16.5% |
| Q1 2021 | $2,594,000 | -38.0% | 247,195 | +0.0% | 0.08% | -42.2% |
| Q4 2020 | $4,186,000 | +41.3% | 247,116 | +7.0% | 0.15% | +23.5% |
| Q3 2020 | $2,962,000 | +43.9% | 230,873 | +58.2% | 0.12% | +35.2% |
| Q2 2020 | $2,059,000 | +65.6% | 145,956 | +8.0% | 0.09% | +27.5% |
| Q1 2020 | $1,243,000 | +42.4% | 135,152 | +130.8% | 0.07% | +130.0% |
| Q4 2019 | $873,000 | – | 58,568 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |